RELCHEMQ NSI Week ended 07 Aug 2026

Weekly Investor Report

Reliance Chemotex Industries Limited · Consumer Cyclical · Textile Manufacturing

Latest close 129.8 INR
5.5% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 4.3% above the Trend Line and sits at 31.6% of its 52-week range. The latest completed week returned 5.5%, after a -1.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal.

Setup score 38 out of 100
Latest Close 129.8 INR 7 Aug 2026
1W Return 5.5% latest completed week
4W Return -1.1% short-term follow-through
12W Return 6.6% quarterly tape
Trend Breadth 9.6% 5 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • 5 accumulation markers appear in the recent smart-money tape.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 4.3% above the Trend Line and sits at 31.6% of its 52-week range. The latest completed week returned 5.5%, after a -1.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4212-week average 0.27

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.42Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

5 accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.1% over four weeks, 6.6% over 12 weeks, and -22.6% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W5.5%
4W-1.1%
12W6.6%
26W-0.4%
52W-22.6%
Active trend streak5 weeks
Active weeks in one year5
Trend breadth9.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.50Latest activity-pressure read.
Pressure change-58.5%Four-week change in activity pressure.
Leadership-3.94Latest relative-leadership reading.
RS change3.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength43/100Blend of value, momentum, and quality. Underlying universe rank 58; rank 1 is best.
Value47/100Relative valuation strength. Underlying universe rank 54; rank 1 is best.
Quality46/100Profitability and accounting quality. Underlying universe rank 55; rank 1 is best.
Momentum49/100Medium-term price momentum. Underlying universe rank 52; rank 1 is best.
Growth47/100Revenue and earnings growth. Underlying universe rank 54; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework59/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
18.6x
Price divided by trailing earnings.
Price / sales
0.3x
Market value relative to trailing revenue.
EV / EBITDA
8.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
45.8%
Gross profit retained from each unit of revenue.
Operating margin
7.2%
Operating profit retained from revenue.
Free-cash-flow margin
5.8%
Free cash flow generated from revenue.
Return on invested capital
4.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
1.0%
Latest one-year revenue growth.
EPS growth
30.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
1059.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.4%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
6.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 12 relevant articles.

4 positive · 8 neutral · 0 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-29.3%Distance below the 52-week high.
13-week volatility4.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+14.0%Week of 12 Jun.
Worst week-5.2%Week of 20 Feb.
Latest week+5.5%Week of 7 Aug.

Shape of recent returns

Strong gains4
Modest gains6
Flat weeks0
Modest losses13
Sharp losses3
Recent vol4.6%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split19/33Count of positive and negative weeks in the 52-week window.
Average skew3.7% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026129.8 INR5.5%124.4 INR188.1 INR0.50-3.949.4KOn
31 Jul 2026123.0 INR-3.3%124.6 INR188.4 INR0.66-8.7419.6KOn
24 Jul 2026127.3 INR-2.5%125.1 INR188.8 INR0.89-3.8419.5KOn
17 Jul 2026130.6 INR-0.4%125.4 INR189.1 INR1.10-4.3313.8KOn
10 Jul 2026131.2 INR-1.4%125.5 INR189.3 INR1.22-4.1010.5KOn
3 Jul 2026133.1 INR-3.8%125.8 INR189.6 INR1.38-3.691.5KOff
26 Jun 2026138.3 INR-0.0%126.2 INR189.9 INR1.310.470Off
19 Jun 2026138.4 INR-2.1%126.6 INR190.2 INR1.230.232.3KOff
12 Jun 2026141.3 INR14.0%126.8 INR190.4 INR1.063.54115.6KOff
5 Jun 2026124.0 INR-1.1%127.3 INR190.7 INR0.78-8.551.9KOff
29 May 2026125.3 INR2.7%128.3 INR191.0 INR0.91-8.9311.7KOff
22 May 2026122.1 INR0.3%129.2 INR191.3 INR0.84-12.7311.4KOff
15 May 2026121.7 INR-2.5%130.4 INR191.6 INR0.84-13.3914.6KOff
8 May 2026124.8 INR9.5%131.6 INR191.9 INR0.89-13.7247.5KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context